An Open Label Study of the use of Aripiprazole in the Treatment of Chronic Post Traumatic Stress Disorder

A pilot Open Label Study of Aripiprazole as Add On Therapy in Post Traumatic Stress disorder as measured by impact on CAPS-2 scores

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000322639

Enrollment

Registered

2005-09-06

Start date

2006-03-09

Completion date

2007-03-30

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This clinical research study was completed in 2009.

Interventions

8 week Open label prescription of Aripiprazole, in addition to any current anti-depressant therapy.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

PTSD according to DSM-IV criteria and a baseline CAPS 2 score greater than 50.

Exclusion criteria

Current substance use disorder.

Outcome results